Publicaciones en las que colabora con MARGARITA CALONGE CANO (8)

2023

  1. In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial

    Ophthalmology and Therapy, Vol. 12, Núm. 6, pp. 3251-3262

2019

  1. A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency

    Translational Research, Vol. 206, pp. 18-40

2015

  1. Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures

    BioMed Research International, Vol. 2015

2009

  1. Genetically engineered elastin-like polymer as a substratum to culture cells from the ocular surface

    Current Eye Research, Vol. 34, Núm. 1, pp. 48-56

1998

  1. Expression of ICAM-1 and HLA-DR by human conjunctival epithelial cultured cells and modulation by nedocromil sodium

    Journal of Ocular Pharmacology and Therapeutics, Vol. 14, Núm. 6, pp. 517-531

1996

  1. Nedocromil Sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro

    Investigative Ophthalmology and Visual Science, Vol. 37, Núm. 3

1993

  1. Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves

    Journal of Biological Chemistry, Vol. 268, Núm. 24, pp. 18195-18199

  2. Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark of Sambucus nigra L.

    Plant Molecular Biology, Vol. 22, Núm. 6, pp. 1181-1186